Qi Wan, Qiong Wang, Ran Wei, Jing Tang, Hongbo Yin, Ying-Ping Deng, Ke Ma
{"title":"Machine learning-based progress prediction in accelerated cross-linking for Keratoconus.","authors":"Qi Wan, Qiong Wang, Ran Wei, Jing Tang, Hongbo Yin, Ying-Ping Deng, Ke Ma","doi":"10.1007/s00417-025-06792-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To analyze corneal topographic and biomechanical parameters in keratoconus patients before undergoing accelerated corneal collagen cross-linking (A-CXL) surgery and use machine learning models to identify prognostic factors for disease progression after treatment.</p><p><strong>Methods: </strong>This was a retrospective, single-center study on 95 eyes from 69 keratoconus patients (mean age 21.46 ± 7.07 years) undergoing A-CXL, with 3-22 months follow-up. Corneal tomography (Pentacam) and biomechanical measurements (Corvis ST) were performed at baseline and follow-up visits. Changes in the E-stage were used to define progression. LASSO, XGBoost, and random forest machine learning models were applied to identify prognostic factors. A nomogram was developed to predict progression probabilities.</p><p><strong>Results: </strong>42.1% of eyes showed progression based on E-stage change. Maximal keratometry (Kmax) and index of surface variance (ISV) were significantly higher in the progression group. The nomogram incorporating Kmax and ISV predicted progression better than individual parameters. The progression rate was 51.4% in high-risk eyes versus 16% in low-risk eyes stratified by the nomogram.</p><p><strong>Conclusions: </strong>Kmax and ISV are important prognostic factors for keratoconus progression after A-CXL. The nomogram can improve prediction accuracy compared to single parameters. It enables personalized risk assessment to guide treatment decisions.</p>","PeriodicalId":12795,"journal":{"name":"Graefe’s Archive for Clinical and Experimental Ophthalmology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Graefe’s Archive for Clinical and Experimental Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00417-025-06792-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To analyze corneal topographic and biomechanical parameters in keratoconus patients before undergoing accelerated corneal collagen cross-linking (A-CXL) surgery and use machine learning models to identify prognostic factors for disease progression after treatment.
Methods: This was a retrospective, single-center study on 95 eyes from 69 keratoconus patients (mean age 21.46 ± 7.07 years) undergoing A-CXL, with 3-22 months follow-up. Corneal tomography (Pentacam) and biomechanical measurements (Corvis ST) were performed at baseline and follow-up visits. Changes in the E-stage were used to define progression. LASSO, XGBoost, and random forest machine learning models were applied to identify prognostic factors. A nomogram was developed to predict progression probabilities.
Results: 42.1% of eyes showed progression based on E-stage change. Maximal keratometry (Kmax) and index of surface variance (ISV) were significantly higher in the progression group. The nomogram incorporating Kmax and ISV predicted progression better than individual parameters. The progression rate was 51.4% in high-risk eyes versus 16% in low-risk eyes stratified by the nomogram.
Conclusions: Kmax and ISV are important prognostic factors for keratoconus progression after A-CXL. The nomogram can improve prediction accuracy compared to single parameters. It enables personalized risk assessment to guide treatment decisions.
期刊介绍:
Graefe''s Archive for Clinical and Experimental Ophthalmology is a distinguished international journal that presents original clinical reports and clini-cally relevant experimental studies. Founded in 1854 by Albrecht von Graefe to serve as a source of useful clinical information and a stimulus for discussion, the journal has published articles by leading ophthalmologists and vision research scientists for more than a century. With peer review by an international Editorial Board and prompt English-language publication, Graefe''s Archive provides rapid dissemination of clinical and clinically related experimental information.